Loading...

ENG KOR

KB STAR ETF 로고

홈으로 이동

KOR ENG

ETF Finder

Home Product Lineup ETF Finder Product Details
Domestic
Equity Passive

RISE Healthcare (253280)

Update : 2026.03.20

NAV

18,575KRW

-0.05하락 (-%)

Market Price per share (KRW)

18,620KRW

+535상승 (2.96%)

※ t-1 last price

trading volume

31,652shares

AUM

KRW 12billion

Share it

RISE Healthcare (253280)

Overview Performance Holdings

KEY POINT

Invest in domestic healthcare companies (medical equipment and services, bio, pharmaceutical)

KEY POINT

Invest in selected healthcare companies based on financial conditions among the top 500 companies by market capitalization of the KOSPI and KOSDAQ markets

Basic information

Download trading information

Update : 2026.03.20
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE HealthCare ETF
(253280) 		FnGuide HealthCare Index 2016.09.23 50,000 12,073,900,894
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 18,620
※ t-1 last price 		18,575 31,652
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%) Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE HealthCare ETF

(253280) 		FnGuide HealthCare Index
Inception date Creation Unit
2016.09.23 50,000
AUM(0.1 billion) (KRW) Trustee
12,073,900,894 하나은행
Market Price per share (KRW) iNAV per share (KRW)
18,620
※ t-1 last price 		18,575
Trading Volume (shares)
31,652
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%)
Distribution Frequency
Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Index is a market capitalization weighted index. The index selects stocks that satisfy financial and management soundness criteria out of the universe of stocks come under the medical sector in the MKF 500.

View detailed index information

TOP 10 Holdings

Update : 2026-03-20
Rank , Name, proportion table
Rank Name Weight (%)
1 SCD 11.72
2 Celltrion 10.10
3 SAMSUNG BIOLOGICS 8.79
4 ABL Bio 8.43
5 Alteogen 7.42
6 HLB 6.29
7 Yuhan 5.83
8 LCB 5.56
9 HanmiPharm 3.45
10 SKBP 2.82

proportion by sectors

*The proportion of investment stocks

Update : 2026.03.20
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2025-04-30 2025-05-07 20
2023-04-28 2023-05-03 16
2022-04-29 2022-05-03 60

Performance

performance

excel download

Update : 2026-03-20

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)		 Since
inception
NAV -3.07 10.29 20.77 34.71 74.06 10.32 83.15
Benchmark Index -3.14 10.39 21.11 35.56 74.97 10.57 85.08
Outperformance 0.07 -0.11 -0.34 -0.86 -0.91 -0.25 -1.93

daily Performance

excel download

-
search
date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW) Standard Tax Base Price (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2026.03.20 18,620 2.958상승 18,575.28 2.980상승 10,377.89
2026.03.19 18,085 -2.031하락 18,037.75 -2.058하락 10,377.19
2026.03.18 18,460 2.073상승 18,416.87 1.988상승 10,377.24
2026.03.17 18,085 1.744상승 18,057.75 1.897상승 10,377.28
2026.03.16 17,775 -1.795하락 17,721.52 -1.877하락 10,377.44
2026.03.13 18,100 0.055상승 18,060.68 0.170상승 10,375.68
2026.03.12 18,090 0.360상승 18,029.96 0.300상승 10,377.76
2026.03.11 18,025 -0.331하락 17,975.9 -0.355하락 10,376.35
2026.03.10 18,085 2.059상승 18,040.06 1.371상승 10,376.43
2026.03.09 17,720 -3.800하락 17,795.97 -3.146하락 10,376.06
2026.03.06 18,420 0.903상승 18,374.2 0.983상승 10,376.21
2026.03.05 18,255 11.344상승 18,195.2 11.517상승 10,376.26
2026.03.04 16,395 -13.023하락 16,315.99 -13.515하락 10,376.31
2026.03.03 18,850 -4.046하락 18,865.69 -4.467하락 10,376.35
2026.02.27 19,645 -0.076하락 19,748.01 1.116상승 10,376.56
2026.02.26 19,660 3.310상승 19,529.95 2.534상승 10,376.61
2026.02.25 19,030 -2.033하락 19,047.26 -1.795하락 10,370.5
2026.02.24 19,425 1.040상승 19,395.43 0.706상승 10,370.02
2026.02.23 19,225 0.286상승 19,259.28 0.501상승 10,370.07

Holdings

search
Download holdings data
Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares Weight(%) Market price (KRW)
1 SCD KR7000250001 133 11.72 105,735,000
2 Celltrion KR7068270008 451 10.1 91,102,000
3 SAMSUNG BIOLOGICS KR7207940008 50 8.79 79,250,000
4 ABL Bio KR7298380007 400 8.43 76,000,000
5 Alteogen KR7196170005 186 7.42 66,960,000
6 HLB KR7028300002 1,125 6.29 56,700,000
7 Yuhan KR7000100008 533 5.83 52,607,100
8 LCB KR7141080002 251 5.56 50,174,900
9 HanmiPharm KR7128940004 60 3.45 31,140,000
10 SKBP KR7326030004 261 2.82 25,447,500
11 PharmaResearch KR7214450009 64 2.27 20,512,000
12 HANALL BIOPHARMA KR7009420001 338 2.08 18,759,000
13 ST Pharm KR7237690003 124 2.06 18,538,000
14 원화예금 KRD010010001 18,365,559 2.04 18,365,559
15 Hugel KR7145020004 51 1.48 13,362,000
16 L&C BIO KR7290650001 159 1.33 11,988,600
17 Celltrionph KR7068760008 197 1.31 11,859,400
18 ORUM KR7475830006 91 1.26 11,365,900
19 CLASSYS KR7214150005 206 1.2 10,815,000
20 SKBS KR7302440003 254 1.18 10,655,300
21 CHA Biotech KR7085660009 517 1.07 9,693,750
22 Pharmicell KR7005690003 535 0.94 8,522,550
23 GC Corp KR7006280002 53 0.85 7,695,600
24 Hanmi Science KR7008930000 194 0.81 7,294,400
25 HK inno.N KR7195940002 136 0.78 6,990,400
26 DAEWOONG PHARM KR7069620003 43 0.76 6,880,000
27 SEEGENE KR7096530001 307 0.75 6,800,050
28 CHONGKUNDANG KR7185750007 76 0.73 6,589,200
29 ILDONG PHARM KR7249420001 202 0.7 6,342,800
30 MedyTox KR7086900008 52 0.61 5,496,400
31 Daewoong KR7003090008 188 0.49 4,446,200
32 CUREXO KR7060280005 278 0.48 4,314,560
33 EuBio KR7206650004 298 0.47 4,267,360
34 HLBPHARMA KR7047920004 267 0.46 4,191,900
35 DongKook Pharm KR7086450004 226 0.45 4,045,400
36 i-SENS KR7099190001 200 0.45 4,060,000
37 Huons Global KR7084110006 52 0.39 3,546,400
38 Binex KR7053030003 276 0.38 3,422,400
39 ShinpoongPharm KR7019170000 317 0.38 3,407,750
40 DENTIUM KR7145720009 63 0.36 3,269,700
41 WONTECH KR7336570007 415 0.32 2,871,800
42 SELVAS AI KR7108860008 227 0.27 2,428,900
43 BioPlus KR7099430001 405 0.22 2,006,775
44 Humedix KR7200670008 57 0.22 2,003,550
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.